[Federal Register Volume 72, Number 90 (Thursday, May 10, 2007)]
[Notices]
[Pages 26637-26638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-9053]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Vaccines and Related Biological Products Advisory Committee; 
Amendment of Notice

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Vaccines and Related Biological 
Products Advisory Committee. This meeting was originally announced in 
the Federal Register of April 16, 2007 (72 FR 19003). The amendment is 
being made to reflect a change in the Date and Time, Agenda, and 
Procedure portions of the meeting.

FOR FURTHER INFORMATION CONTACT: Christine Walsh or Denise Royster, 
Center for Biologics Evaluation and Research (HFM-71), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 3014512391.

SUPPLEMENTARY INFORMATION:  In the Federal Register of April 16, 2007, 
FDA announced that a meeting of the Vaccines and Related Biological 
Products Advisory Committee would be held on May 16, 2007, from 9 a.m. 
to 4:30 p.m. and May 17, 2007, from 8 a.m. to 1 p.m. Changes to the 
meeting times, agenda, and procedure are as follows:
     The meeting will be held on May 16, 2007, from 8:30 a.m. 
to 4:45 p.m. and on May 17, 2007, from 9 a.m. to 3:30 p.m.
     In addition to the agenda items listed in the April 16, 
2007, meeting notice, on May 16, 2007, in the afternoon session, the 
committee will hear an update on the influenza strain selection for the 
2007 to 2008 influenza season. As stated in the April 16, 2007, meeting 
notice, FDA intends to make background material available to the public 
no later than 1 business day before the meeting. If FDA is unable to 
post the background material on its Web site prior to the meeting, the 
background material will be made publicly available at the location of 
the advisory committee meeting, and the background material will be 
posted on FDA's Web site after the meeting. Background material is 
available at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm, click on 
the year 2007 and scroll down to the appropriate advisory committee 
link.
     On May 16, 2007, from 8:30 a.m. to 4:05 p.m. and on May 
17, 2007, from 9 a.m. to 3:30 p.m., the meeting is open to the public. 
Interested persons may present data, information, or views, orally or 
in writing, on issues pending before the committee. Oral presentations 
from the public will be scheduled between approximately 11:25 a.m. and 
11:55 a.m. and between 3:35 p.m. and 4:05 p.m. on May 16, 2007, and 
between approximately 12:45 p.m. and 1:15 a.m. on May 17, 2007.
     On May 16, 2007, from 4:05 p.m. to 4:45 p.m., the meeting 
will be closed to

[[Page 26638]]

permit discussion where disclosure would constitute a clearly 
unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)).
    There are no other changes to the meeting.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: May 7, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E7-9053 Filed 5-9-07; 8:45 am]
BILLING CODE 4160-01-S